Apollo Commercial Real Estate Finance Inc (ARI) concluded trading on Wednesday at a closing price of $9.11, with 4.23 million shares of worth about $38.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.53% during that period and on December 04, 2024 the price saw a loss of about -0.22%. Currently the company’s common shares owned by public are about 138.17M shares, out of which, 136.61M shares are available for trading.
Stock saw a price change of -1.73% in past 5 days and over the past one month there was a price change of 1.45%. Year-to-date (YTD), ARI shares are showing a performance of -22.40% which decreased to -18.44% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $8.52 but also hit the highest price of $12.74 during that period. The average intraday trading volume for Apollo Commercial Real Estate Finance Inc shares is 1.21 million. The stock is currently trading -0.75% below its 20-day simple moving average (SMA20), while that difference is up 1.14% for SMA50 and it goes to -9.51% lower than SMA200.
Apollo Commercial Real Estate Finance Inc (NYSE: ARI) currently have 138.17M outstanding shares and institutions hold larger chunk of about 64.74% of that.
The stock has a current market capitalization of $1.26B and its 3Y-monthly beta is at 1.80. It has posted earnings per share of -$0.93 in the same period. It has a debt-to-equity ratio of 3.81. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARI, volatility over the week remained 1.74% while standing at 2.08% over the month.
Stock’s fiscal year EPS is expected to drop by -60.81% while it is estimated to increase by 97.37% in next year. EPS is likely to grow at an annualized rate of 0.07% for next 5-years, compared to annual growth of -27.62% made by the stock over the past 5-years.
Coverage by BofA Securities stated Apollo Commercial Real Estate Finance Inc (ARI) stock as an Underperform in their note to investors on March 04, 2024, suggesting a price target of $10.50 for the stock. On December 06, 2023, UBS Initiated their recommendations, while on August 02, 2023, JP Morgan Upgrade their ratings for the stock with a price target of $10.50. Stock get a Neutral rating from BTIG Research on April 25, 2023.
